Dr. Wakefield: Hep B vax studies lasted 5 days, no placebo, and weren’t conducted on newborns

Dr. Wakefield: Hep B vaccine studies lasted 5 days, involved no placebo, and weren’t conducted on newborns—yet it’s hospital policy!

watch the full podcast: "I Saw What The Vax Did" - Michael Knowles & The Vax Dissident | Dr. Andy Wakefield https://rumble.com/v6tiwqt-i-saw-what-the-vax-did-michael-knowles-and-the-vax-dissident-dr.-andy-wakef.html?mref=1bxo9j&mc=69gy3

Dr. Andrew Wakefield raises serious questions about the hepatitis B vaccine, given to infants within their first 24 hours of life. In a detailed conversation with Michael Knowles, Wakefield critiques the policy’s foundation, highlighting a concerning lack of robust safety data.

The studies for this vaccine lasted just 5 days, included no placebo group, and—shockingly—weren’t conducted on newborns. Instead, they involved a small, non-representative group, offering no basis to infer safety for day-old infants. Yet, this vaccine is standard hospital policy across the United States.

Wakefield reveals the troubling motive behind this decision. Merck, the vaccine’s manufacturer, struggled to market it to high-risk groups like prostitutes and drug addicts, who weren’t compliant. As Wakefield notes, Merck told the Advisory Committee on Immunization Practices (ACIP), “We are not going to be left with an orphan drug.”

With no viable market, they shifted to vaccinating every newborn. The ACIP, responsible for public health guidance, agreed, prioritizing industry interests over infant safety. The result? A policy driven more by corporate strategy than science.

Knowles, surprised, stressed that parents deserve better. “I would like that safety study to have been conducted years and years ago,” he said, calling for rigorous, long-term research—at least five to ten years—before vaccinating children. Most parents would agree: informed consent requires clear information about risks, benefits, and evidence quality.

Yet, Wakefield points out, neither parents nor doctors are fully informed. Many doctors administering the vaccine are unaware of the studies’ limitations. How can parents make informed choices without access to critical details?

The implications are significant. Hepatitis B is primarily transmitted through blood, sexual contact, or needle-sharing—risks nearly nonexistent for newborns. Mothers can be tested for hepatitis B during pregnancy, allowing targeted vaccination if needed. So why vaccinate every infant on day one? Wakefield calls the policy illogical and a breach of medical ethics, bypassing parental rights.

This issue extends beyond one vaccine—it’s about trust in health systems. When industry influences policy and inadequate studies underpin mandates, the public deserves answers. Why are newborns given a vaccine with such limited safety data? Why is there no long-term follow-up? And why aren’t parents told the full story?